• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,3'-二取代双极联苯作为核受体共激活剂结合抑制剂。

3,3'-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding.

机构信息

Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA.

出版信息

Bioorg Med Chem Lett. 2012 Nov 1;22(21):6587-90. doi: 10.1016/j.bmcl.2012.09.007. Epub 2012 Sep 13.

DOI:10.1016/j.bmcl.2012.09.007
PMID:23017882
Abstract

A series of bipolar biphenyl compounds was synthesized as proteomimetic analogs of the LXXLL penta-peptide motif responsible for the binding of coactivator proteins to the nuclear hormone receptor coactivator binding domain. These compounds were subjected to multiple in vitro assays to evaluate their effectiveness as competitive binding inhibitors. The results from this initial study indicate that these proteomimetics possess the ability to inhibit this protein-protein interaction.

摘要

一系列双极性联苯化合物被合成,作为负责与核激素受体共激活剂结合域结合的共激活蛋白的 LXXLL 五肽基序的蛋白质模拟物类似物。这些化合物经过多种体外测定来评估它们作为竞争性结合抑制剂的有效性。这项初步研究的结果表明,这些蛋白质模拟物具有抑制这种蛋白质-蛋白质相互作用的能力。

相似文献

1
3,3'-Disubstituted bipolar biphenyls as inhibitors of nuclear receptor coactivator binding.3,3'-二取代双极联苯作为核受体共激活剂结合抑制剂。
Bioorg Med Chem Lett. 2012 Nov 1;22(21):6587-90. doi: 10.1016/j.bmcl.2012.09.007. Epub 2012 Sep 13.
2
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.4,4'-不对称取代的3,3'-联苯α螺旋蛋白质模拟物作为潜在的共激活因子结合抑制剂
Bioorg Med Chem. 2014 Jan 15;22(2):917-26. doi: 10.1016/j.bmc.2013.10.051. Epub 2013 Nov 8.
3
Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.联苯类蛋白质模拟物的合成及其作为雌激素受体-α共激活剂结合抑制剂的研究。
Org Lett. 2009 Dec 3;11(23):5370-3. doi: 10.1021/ol901999f.
4
Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.发现小分子雌激素受体 α/共激活剂结合抑制剂:高通量筛选、配体开发和增强效力的模型。
ChemMedChem. 2011 Apr 4;6(4):654-66. doi: 10.1002/cmdc.201000507. Epub 2011 Mar 1.
5
Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.海克素在乳腺癌细胞中作为雌激素受体 α 的共调节剂发挥作用。
Cancer Sci. 2010 Sep;101(9):2019-25. doi: 10.1111/j.1349-7006.2010.01636.x.
6
The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors.p160共激活因子PAS - B基序可稳定核受体结合,并有助于甲状腺激素受体进行亚型特异性调控。
J Biol Chem. 2009 Jul 17;284(29):19554-63. doi: 10.1074/jbc.M109.007542. Epub 2009 Jun 1.
7
Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.雌激素受体α与CREB结合蛋白共激活因子的相互作用受细胞环境调控。
J Mol Endocrinol. 2004 Feb;32(1):307-23. doi: 10.1677/jme.0.0320307.
8
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.发现维生素 D 受体与共激活因子相互作用的首个不可逆小分子抑制剂。
J Med Chem. 2012 May 24;55(10):4640-51. doi: 10.1021/jm300460c. Epub 2012 May 16.
9
P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.P160/SRC/核受体辅激活因子通过其PAS - B结构域与CID/AD1结构域的特异性相互作用形成复合物。
Nucleic Acids Res. 2008 Apr;36(6):1847-60. doi: 10.1093/nar/gkn029. Epub 2008 Feb 11.
10
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.雌激素受体α共激活因子结合小分子抑制剂的设计、合成及体外生物学评价
J Med Chem. 2004 Jan 29;47(3):600-11. doi: 10.1021/jm030404c.

引用本文的文献

1
Steroid receptor/coactivator binding inhibitors: An update.甾体激素受体/共激活因子结合抑制剂:最新进展。
Mol Cell Endocrinol. 2019 Aug 1;493:110471. doi: 10.1016/j.mce.2019.110471. Epub 2019 Jun 1.
2
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.4,4'-不对称取代的3,3'-联苯α螺旋蛋白质模拟物作为潜在的共激活因子结合抑制剂
Bioorg Med Chem. 2014 Jan 15;22(2):917-26. doi: 10.1016/j.bmc.2013.10.051. Epub 2013 Nov 8.